Strides Pharma Science Ltd - Share Price

STAR

Open

377.20

Prev. Close

378.05

Turnover (lac.)

1,041

Day's High

381.90

Day's Low

370.25

52 Week's High

551.40

52 Week's Low

288.00

Book Value

372

Face Value

10

Mkt Cap (Cr.)

3,341

P/E

18

EPS

21

Divi. Yield

0.79

Financials

Switch to
Consolidated
Standalone

Loading ...

News & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd427.0039.31102,811.50823.160.643,215.0198.33
Dr Reddys Laboratories Ltd2,908.7519.1048,053.031,365.100.693,435.30852.70
Divis Laboratories Ltd1,806.3036.7247,339.68352.830.901,403.92266.77
Cipla Ltd447.9015.5636,731.62737.380.663,230.08209.72
Biocon Ltd289.20116.5534,686.00106.100.17523.9059.29

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

sentifi.com

Indiainfoline Sentifi Top 10 Most Talked About Stocks

Summary & Reports

Strides Pharma Science Limited is an integrated manufacturer and exporter of finished pharmaceutical dosage forms for both branded and generic. The company manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals. Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semi-solids. They undertake contract research and manufacturing of specialty chemicals. ... More

Registered Office

No 201 Devavrata Sector 17,Vashi,Navi Mumbai, Maharashtra,400703

Tell. : +91-22-27892924/27893199
Website : http://www.stridesarco.com
Email : investors@stridesshasun.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67161500
Website : www.karvyfintech.com
Email : einward.ris@karvy.com

Latest Release by strides-pharma-science-ltd

View

- <

Reco. Price

Dec 04,2019 11:36 AM

Target Price

Target Returns:

0.00%

Result Express

Strides Arcolab Ltd's Q3FY19 consolidated net profit declines 38.09% yoy to Rs30.83cr : In-line with Estimates

Dec 09, 2019 06:21 PM

The company’s consolidated revenue stood at Rs794.50cr, up 6.07% yoy and 8.44% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    25 Oct 2019

    Annc. Date

    18 Oct 2019

    Quarterly ResultsThis has reference to our letter dated October 19, 2019 relating to intimation of B... More

  • Purpose

    Board Meeting

    Exp. Date

    20 Sep 2019

    Annc. Date

    20 Sep 2019

    The Board of Directors of the Company in their meeting held today i.e., September 20, 2019 has grant... More

  • Purpose

    Dividend

    Annc. Date

    29 Jul 2019

    Effective. Date

    22 Aug 2019

    Divi. Type

    Interim

    Divi.(%)

    120

    Divi. Amt.

    12

    We wish to inform you that the Board of Directors at their meeting held today i.e., July 29, 2019, i... More